Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Feb;78(916):63-70.
doi: 10.1136/pmj.78.916.63.

Subacute sclerosing panencephalitis

Affiliations
Review

Subacute sclerosing panencephalitis

R K Garg. Postgrad Med J. 2002 Feb.

Abstract

Subacute sclerosing panencephalitis (SSPE) is a progressive neurological disorder of childhood and early adolescence. It is caused by persistent defective measles virus. Brain biopsies or postmortem histopathological examination show evidence of astrogliosis, neuronal loss, degeneration of dendrites, demyelination, neurofibrillary tangles, and infiltration of inflammatory cells. Patients usually have behavioral changes, myoclonus, dementia, visual disturbances, and pyramidal and extrapyramidal signs. The disease has a gradual progressive course leading to death within 1-3 years. The diagnosis is based upon characteristic clinical manifestations, the presence of characteristic periodic EEG discharges, and demonstration of raised antibody titre against measles in the plasma and cerebrospinal fluid. Treatment for SSPE is still undetermined. A combination of oral isoprinosine (Inosiplex) and intraventricular interferon alfa appears to be the best effective treatment. Patients responding to treatment need to receive it life long. Effective immunisation against measles is the only solution presently available to the problem of this dreaded disease.

PubMed Disclaimer

References

    1. J Virol. 1998 Feb;72(2):1224-34 - PubMed
    1. J Neuroimmunol. 1982 Jan;2(1):27-34 - PubMed
    1. Neurology. 1996 Nov;47(5):1278-83 - PubMed
    1. Int J Epidemiol. 1992 Oct;21(5):998-1006 - PubMed
    1. Infect Immun. 1972 Sep;6(3):248-54 - PubMed

Substances